Literature DB >> 31838876

Peritonitis Secondary to Uncommon Gram-Negative Coccobacillus Transmitted From a Cat in a Patient on Peritoneal Dialysis.

Sreedhar Adapa1, Srikanth Naramala2, Bhaskar Reddy Madhira3, Vijay Gayam4, Prem Sahasranam5, Venu Madhav Konala6.   

Abstract

Peritonitis caused by gram-negative organisms is a significant complication encountered in patients undergoing peritoneal dialysis and is associated with high morbidity and mortality. There has been recognition of peritonitis caused by uncommon organisms because of improved microbiological detection techniques. In this article, we report a rare case of peritonitis caused by Pasteurella multocida. We present a 58-year-old male on peritoneal dialysis with fever and abdominal pain. The peritoneal fluid was cloudy, and the analysis was consistent with peritonitis. The peritoneal fluid culture grew Pasteurella multocida. The patient was treated with a 3-week course of intraperitoneal ceftazidime, which resulted in the resolution of infection with the salvation of the peritoneal dialysis catheter. Patient education plays a very critical role in the prevention of peritonitis from Pasteurella multocida, particularly if patients have pets at home. The domestic pets should be kept away from the dialysis equipment and should not be allowed into the room during dialysis treatment. Incorporating the education in handing pets during the training session is the key aspect.

Entities:  

Keywords:  Pasteurella multocida; cats; gram-negative coccobacilli; peritoneal dialysis; peritonitis

Year:  2019        PMID: 31838876      PMCID: PMC6913050          DOI: 10.1177/2324709619895165

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


Introduction

Peritonitis caused by gram-negative organisms is a significant complication encountered in patients undergoing peritoneal dialysis (PD) and is often associated with high morbidity and mortality.[1] Pasteurella multocida is an aerobic and facultative anaerobic gram-negative coccobacillus, which is a normal commensal of oropharynx of many animals but is predominant in domestic pets like cats and dogs.[2] It was first identified in 1878 by Perroncito and was named after Louis Pasteur in 1880 who described this bacterium in diseased birds.[3] This bacterium is found in the oropharynx of 30% of live stockbreeders.[4] Infection with bacteria is rare in humans but commonly occurs in immunocompromised patients. It is susceptible to most common antibiotics.

Case Report

A 58-year-old male on PD presented to the outpatient dialysis clinic with a chief complaint of fever, abdominal pain, and cloudy effluent for 1-day duration. He denied any touch contamination. The patient has been on PD for 4 months. He has been working as a supervisor and it was a desk job. The patient denied any history of smoking, alcohol intake, or illicit drug use. The patient is married and has cats as domestic pets. The patient admitted that the cats were present in the room while he was performing PD. As per the patient, he always washed his hands while accessing PD equipment. The patient had not witnessed that the cats licked, bitten, or scratched the PD equipment. There was no leakage witnessed in the PD equipment. Past medical history is signification for polycystic kidney disease, diabetes, hypertension, hyperlipidemia, hyperparathyroidism, hypothyroidism, seizure disorder, end-stage renal disease secondary to polycystic kidney disease on PD. His home medications include atorvastatin 40 mg daily at night time, ferric citrate 210 mg one tablet 3 times a day with meals, sevelamer 800 mg 3 tablets 3 times a day with meals, omega 3 fatty acid 1 capsule daily, lactulose 20 g daily as needed for constipation, levetiracetam 500 mg twice a day, levothyroxine 100 µg daily, metoprolol 25 mg twice a day, cinacalcet 30 mg daily, and renal vitamin 1 tablet daily. The vital signs on presentation were the temperature of 100.2°F, pulse rate of 74 beats per minute, respiratory rate of 18 breaths per minute, and blood pressure of 143/82 mm Hg. Physical examination reveals diffuse abdominal tenderness with a PD catheter in the right lower quadrant. There is neither exit site drainage nor redness along the tunnel of the catheter. The rest of the physical examination was unremarkable. Laboratory data revealed white blood cell (WBC) count 5500/mm3, hemoglobin 11.3 g/dL, platelet count 260 000/mm3, sodium 142 mmol/L, potassium 4.2 mmol/L, bicarbonate 21 mmol/L, blood urea nitrogen 51 mg/dL, creatinine 13.8 mg/dL, and albumin 3.5 g/dL. The peritoneal fluid effluent revealed peritoneal fluid WBC 4576 cells/µL with 94% neutrophils. Peritoneal fluid gram stain revealed >100 WBC count and no organisms seen. The patient was started on empiric treatment with intraperitoneal (IP) vancomycin and ceftazidime for peritonitis. Peritoneal fluid culture grew P multocida in both aerobic and anaerobic bottles. The sensitivities of P multocida are listed in Table 1.
Table 1.

Sensitivities of Pasteurella multocida.

AntibioticMinimum Inhibitory ConcentrationSensitivity Result (S = Sensitive, R = Resistant)
Ampicillin0.5 µg/mLS
Ceftazidime≤0.03 µg/mLS
Chloramphenicol1 µg/mLS
Levofloxacin<0.03 µg/mLS
Penicillin0.25 µg/mLS
Trimethoprim/sulfamethoxazole0.25/4.75 µg/mLS
Sensitivities of Pasteurella multocida. Antibiotic therapy subsequently tailored to IP ceftazidime as per sensitivities for 3 weeks. The repeat peritoneal fluid cultures after finishing antibiotic course yielded no bacterial growth, and the PD catheter was salvaged. The patient was counseled to prevent pets from contaminating the dialysis supplies or pets from entering the treatment room.

Discussion

Peritonitis is an important and serious complication often resulting in PD catheter loss and change in dialysis modality. When the infection does not respond to the routine treatment, infection from unusual organisms should be suspected including zoonosis. There has been increased recognition of peritonitis caused by rare organisms like P multocida, which is related to close contact with pets. Pets are an integral part of many households and share close bonding with the owners. Pets play a crucial role in coping with stress and provide psychological support. The close contact with the pets poses potential health risks like infections, allergies, and injuries sustained from bites, scratches, and attacks. Close contact with pets should prompt the health care provider to suspect zoonosis.[5] The first case of P multocida PD-associated peritonitis was reported in 1987.[6] Peritonitis from this organism has been reported infrequently but has been recognized as a significant cause. The increase in the number of cases reported might be attributed to the increased pet breeding at home. We summarized all the cases listed as P multocida peritonitis on literature review from PubMed in Table 2. Cats cause most of the PD-related peritonitis from P multocida, accounting for more than 90%of the cases.[2] Mode of transmission of this zoonotic organism is through the licks, bites, and scratches of the pets.[2] Transmission can also be from contamination of the dialysis machine and tubes. Another possible way of transmission is hand contamination from the patient’s oropharyngeal colonization of P multocida.[4]
Table 2.

Summary of All the Cases Listed as Pasteurella multocida Peritonitis With Patients on Dialysis as per PubMed Review of Literature.

AuthorYearAge/GenderDuration (Months)Dialysis ModeLeakageDialysate CultureAnimal ExposureTreatmentOutcome
Paul and Rostand[6]198755/female4CCPDPresentPositiveCat bite/scratchGentamicinImproved
Frankel and Cassidy[7]199155/male15CAPDAbsentPositiveCat exposureGentamicin, ciprofloxacinImproved
London and Bottone[8]199154/male6CCPDPresentPositiveCat biteCefazolin, gentamicinImproved
Elsey et al[9]199125/male≤24CCPDAbsentPositiveCat exposureCephradine, gentamicinImproved
Kitching et al[10]199675/male6CAPDPresentPositiveCat biteCefamandoleImproved
Uribarri et al[11]199642/female108CCPDPresentPositiveCat bitePenicillin, gentamicinImproved
Loghman-Adham[12]199712/female7CCPDPresentPositiveCat biteCephapirin, gentamicinImproved
Mackay et al[13]199773/male12CAPDAbsentPositiveCat exposureCeftazidimeImproved
Joh et al[14]199855/male12CCPDPresentPositiveCat biteAmpicillin/sulbactam, gentamicinImproved
Musio and Tiu[15]199846/female7CCPDAbsentPositiveCat exposurePiperacillin, ciprofloxacinImproved
Hamai et al[16]199949/male4CCPDPresentPositiveCat exposureCefazolin, tobramicinImproved
Chadha and Warady[17]199916/male60CCPDPresentPositiveCat biteTicarcillin, tobramicin
Van Langenhove et al[18]200022/female12CCPDPresentPositiveCat scratchAmikacin, ciprofloxacinImproved
Martinez et al[19]200046/femaleNACCPDNAPositiveNACeftazidimeNA
Kanaan et al[20]200224/female7CCPDAbsentPositiveCat exposureCiprofloxacinImproved
Sillery et al[21]200448/female36CAPDAbsentPositiveCat exposureCefazolin, gentamicin, ampicillinImproved
Cooke et al[22]200473/female8 and 12CAPDPresentPositiveCat biteGentamicin, ciprofloxacinImproved
Mat et al[23]200552/male3CCPDPresentPositiveCat exposureCefazolin, amikacinImproved
Malik et al[24]200521/female36CCPDPresentPositiveCat biteGentamicin, cefazolin piperacillin/tazobactamImproved
Malik et al[24]200558/male12CCPDPresentPositiveCat biteGentamicinImproved
Olea et al[25]200646/female24CCPDAbsentPositiveCat exposureCeftazidimeImproved, catheter removed
Antony and Oglesby[26]200748/femaleNACAPDAbsentPositiveDog exposureCefazolin, gentamicinImproved
Rondon-Berrios and Trevejo-Nunez[4]201038/male60CCPDPresentPositiveCat exposurePiperacillin/tazobactam, ampicillin, levofloxacinImproved, catheter removed
Mugambi and Ullian[27]201036/femaleNACCPDAbsentPositiveCat exposureGentamicin, ciprofloxacinImproved, catheter removed
Satomura et al[28]201058/maleCCPDAbsentPositiveCat exposureCefazolin, levofloxacinImproved
Nishina et al[29]201145/male84CCPDPresentPositiveCat exposureCeftazidime, levofloxacinImproved
Weiss and Panesar[30]201257/male1CAPDAbsentpositiveCat and dog exposureVancomycin, ceftazidimeImproved
Sol et al[31]20137/female24NIPDPresentPositiveCat exposureAmpicillinImproved
Kim et al[2]201425/female24CAPDAbsentPositiveCat exposureCefazolin, gentamicinImproved
Dresselaars et al[32]201462/female37CAPDAbsentPositiveCat exposureCefalothin, ciprofloxacinImproved
Poliquin et al[33]201528/female1CAPDPresentPositiveCat biteCeftazidimeImproved
Poliquin et al[33]201537/male15CAPDAbsentPositiveCat biteCefazolinImproved
Poliquin et al[33]201541/male18CAPDNAPositiveCat biteCefazolinImproved
Poliquin et al[33]201551/female7CAPDAbsentPositiveCat exposureAmoxicillin-clavulanic acidImproved
Poliquin et al[33]201537/female132CAPDAbsentPositiveCat exposureCeftriaxone, amoxicillinImproved, catheter removed
Poliquin et al[33]201559/female36CAPDAbsentPositiveCat exposureCeftazidimeImproved
Poliquin et al[33]201569/female1CAPDNAPositiveCat biteCeftazidimeImproved
Giron et al[34]201772/male24CCPDPresentPositiveCat bitCeftazidimeImproved

Abbreviations: CCPD, continuous cyclic peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; NA, not available; NIPD, nocturnal intermittent peritoneal dialysis.

Summary of All the Cases Listed as Pasteurella multocida Peritonitis With Patients on Dialysis as per PubMed Review of Literature. Abbreviations: CCPD, continuous cyclic peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; NA, not available; NIPD, nocturnal intermittent peritoneal dialysis. In an analysis of 124 patients on PD done by Broughton et al,[5] 12 different zoonotic organisms caused peritonitis and animals were involved in 24% of the cases. Catheter loss occurred in 27% of the patients, and the overall mortality was 24%. Pasteurella species peritonitis was reported in 24 patients, and cats were involved in 21 cases. Other pets involved were dogs and hamsters.[5] This bacterium is normal commensal in 50% to 90% of cats and 50% to 66% of the dogs in their oral cavity. It is also present in the claws of 20% of the cats.[35] As per Nishina et al, two thirds of the patients presented with peritonitis within 12 months of initiation of PD.[29] Most of the reported cases of peritonitis associated with this pathogen were due to close contact with cats or puncturing of the dialysis tubing by cats. The bacterium is implicated in soft tissue infections, septic arthritis, pneumonia, and endocarditis in humans.[36] Invasive infections are more common in immunocompromised patients including cirrhosis, alcoholism, malignancy, diabetes mellitus, human immune virus deficiency infection, chronic pulmonary disease, and chronic kidney disease.[37] Life-threatening infections reported including infective endocarditis and sepsis.[36] Patients doing continuous ambulatory PD are less prone to develop peritonitis from P multocida compared with patients on continuous cyclic PD because of fewer chances for the pets to come in contact with the dialysis bags and tubing. The patients who had peritonitis from P multocida were either on continuous cyclic PD or nocturnal intermittent PD in most of the cases reported.[2,29] The pets, mostly cats, play with the longer dialysis tubes.[2] The dialysis tube trembling and the pump sound on the cycler may be an attractive toy for the cats.[29] Patients who are initiated on PD should be questioned about the pets they own or the intention of owning the pets. Incorporating the education on proper handling of the pets during training sessions plays a very critical role in the prevention of peritonitis from P multocida. Regular care of the pets, careful hand washing, proper disposal of animal waste, and placing barriers that limit the access of the pet to the dialysis equipment are the interventions that showed a significant impact on the behavior of patients toward pets. Abebe et al demonstrated this at a single dialysis center resulting in the resolution of pets-related peritonitis.[38] Most reported cases of peritonitis from P multocida mostly by contact from pets reiterates the importance of personal hygiene. Pasteurella multocida peritonitis symptoms are evident as early as 24 hours with fever, cloudy effluent, and severe abdominal pain.[4] Dialysis cultures are usually positive, with negative gram stain and blood cultures.[4] P multocida organisms produce a characteristic mousy odor and grow on blood or chocolate agar at 37°C.[39] Molecular techniques like DNA sequencing and 16S rRNA gene polymerase chain reaction are used for rapid identification and characterization of P multocida with 16S rRNA gene polymerase chain reaction most commonly used at present.[40] Symptoms improve rapidly within 48 to 96 hours after initiation of treatment.[4] P multocida is susceptible to most of the antibiotics, which covers gram-negative bacteria.[29] The IP antibiotic treatment for 3 weeks is sufficient.[2] The most frequently used antibiotic is gentamicin.[29] Pasteurella can produce β-lactamases and can be penicillin resistant, and hence, ampicillin/sulbactam, amoxicillin/clavulanate, and piperacillin/tazobactam are recommended for the treatment.[29] There is a high likelihood of PD catheter salvage, with catheter removal in only 11% of cases. There has been no mortality reported with P multocida peritonitis.[34]

Conclusion

Education plays a very critical role in the prevention of peritonitis from P multocida, particularly if patients have pets at home. Hand washing, regular pet care, proper handling of animal waste, and adding barriers that will prevent pets from accessing the PD equipment are the potential interventions. Preventing the pets from entering the room while making connections and treatment also alleviates the risk of peritonitis from P multocida. Incorporating education in handing pets during the training session is a crucial aspect.
  39 in total

Review 1.  [Abdominal infection by Pasteurella spp. A report of 3 cases].

Authors:  J R Bretón Martínez; M Salavert Lletí; A Viudes Fuster; C Pérez Bellés; M Gobernado Serrano
Journal:  Rev Clin Esp       Date:  2000-03       Impact factor: 1.556

2.  Pets or pest: peritoneal dialysis-related peritonitis due to Pasteurella multocida.

Authors:  Helbert Rondon-Berrios; Giraldina J Trevejo-Nunez
Journal:  J Microbiol Immunol Infect       Date:  2010-04       Impact factor: 4.399

3.  Pasteurella multocida peritonitis: another risk of animal-assisted therapy.

Authors:  John Sillery; James Hargreaves; Philip Marin; Edgar Lerma; Cathy Kuznia; Claudette Abbe
Journal:  Infect Control Hosp Epidemiol       Date:  2004-01       Impact factor: 3.254

4.  Bacteremia, sepsis, and peritonitis with Pasteurella multocida in a peritoneal dialysis patient.

Authors:  S M Mugambi; M E Ullian
Journal:  Perit Dial Int       Date:  2010 May-Jun       Impact factor: 1.756

5.  Pasteurella multocida peritonitis in CAPD: beware of the cats.

Authors:  A H Frankel; M J Cassidy
Journal:  Perit Dial Int       Date:  1991       Impact factor: 1.756

Review 6.  Pasteurella multocida peritonitis following cat bite of peritoneal dialysis tubing. With a brief review of the literature.

Authors:  J Joh; R Padmanabhan; B Bastani
Journal:  Am J Nephrol       Date:  1998       Impact factor: 3.754

7.  [Pasteurella multocida and Candida albicans peritonitis].

Authors:  T Olea; C Hevia; M A Bajo; G del Peso; R Selgas
Journal:  Nefrologia       Date:  2006       Impact factor: 2.033

8.  Capnocytophaga canimorsus peritonitis in a pediatric peritoneal dialysis patient.

Authors:  V Chadha; B A Warady
Journal:  Pediatr Nephrol       Date:  1999-10       Impact factor: 3.714

9.  Pasteurella multocida infection in continuous ambulatory peritoneal dialysis.

Authors:  A R Kitching; A Macdonald; P J Hatfield
Journal:  N Z Med J       Date:  1996-02-23

10.  Peritonitis associated with Pasteurella multocida: molecular evidence of zoonotic etiology.

Authors:  Atsushi Satomura; Mitsuru Yanai; Takayuki Fujita; Yasutomo Arashima; Kazunari Kumasaka; Chie Nakane; Ken Ito; Yoshinobu Fuke; Takashi Maruyama; Noriaki Maruyama; Kazuyoshi Okada; Tomohiro Nakayama; Koichi Matsumoto
Journal:  Ther Apher Dial       Date:  2010-06       Impact factor: 1.762

View more
  1 in total

1.  Pasteurella multocida Bacteremia Secondary to Peritoneal Dialysis Associated Peritonitis: A Case Report and Literature Review.

Authors:  John M Giacona; Maxwell Weiner; John Hanna; Tomasz Jodlowski; Roger Bedimo
Journal:  Cureus       Date:  2022-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.